Acquired Loss of Erythrocyte Complement Receptor Type 1 in Patients with Diabetic Nephropathy Undergoing Hemodialysis

Publisher： Karger

E-ISSN： 1660-2129|104|3|e89-e95

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.104, Iss.3, 2006-07, pp. : e89-e95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reducing Serum Uric Acid Attenuates TGF-β1-Induced Profibrogenic Progression in Type 2 Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 121, Iss. 3-4, 2013-01 ,pp. : e109-e121

Karger

Access to resources Recommend Favorite

Effect of Combination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D3 in Type 2 Diabetic Nephropathy in KK-Ay/Ta Mice

By  

Nephron Experimental Nephrology, Vol. 117, Iss. 4, 2010-10 ,pp. : e124-e132

Karger

Access to resources Recommend Favorite

C-106T Polymorphism in Promoter of Aldose Reductase Gene Is a Risk Factor for Diabetic Nephropathy in Type 2 Diabetes Patients with Poor Glycaemic Control

By  

Nephron Experimental Nephrology, Vol. 99, Iss. 3, 2005-01 ,pp. : e63-e67

Karger

Access to resources Recommend Favorite

Reduction in Mean Glomerular Pore Size Coincides with the Development of Large Shunt Pores in Patients with Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 9, Iss. 1, 2000-10 ,pp. : 49-53

Karger

Access to resources Recommend Favorite

Renoprotective Effect of Pioglitazone by the Prevention of Glomerular Hyperfiltration through the Possible Restoration of Altered Macula Densa Signaling in Rats with Type 2 Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 122, Iss. 3-4, 2013-03 ,pp. : 83-94

Karger

Access to resources Recommend Favorite